INTREPID POTASH INC (IPI) Stock Fundamental Analysis
NYSE:IPI - New York Stock Exchange, Inc. - US46121Y2019 - Common Stock - Currency: USD
Overall IPI gets a fundamental rating of 3 out of 10. We evaluated IPI against 85 industry peers in the Chemicals industry. No worries on liquidiy or solvency for IPI as it has an excellent financial health rating, but there are worries on the profitability. IPI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
IPI had positive earnings in the past year.
IPI had a positive operating cash flow in the past year.
In multiple years IPI reported negative net income over the last 5 years.
In the past 5 years IPI always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of IPI (-34.11%) is worse than 88.24% of its industry peers.
With a Return On Equity value of -42.78%, IPI is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 0.13%, IPI is doing worse than 77.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.11% | ||
| ROE | -42.78% | ||
| ROIC | 0.13% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IPI's Operating Margin of 0.35% is on the low side compared to the rest of the industry. IPI is outperformed by 77.65% of its industry peers.
IPI's Gross Margin of 13.64% is on the low side compared to the rest of the industry. IPI is outperformed by 76.47% of its industry peers.
In the last couple of years the Gross Margin of IPI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 13.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IPI is destroying value.
The number of shares outstanding for IPI has been increased compared to 1 year ago.
IPI has less shares outstanding than it did 5 years ago.
IPI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.74 indicates that IPI is not a great score, but indicates only limited risk for bankruptcy at the moment.
IPI's Altman-Z score of 2.74 is fine compared to the rest of the industry. IPI outperforms 75.29% of its industry peers.
The Debt to FCF ratio of IPI is 0.25, which is an excellent value as it means it would take IPI, only 0.25 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.25, IPI belongs to the best of the industry, outperforming 97.65% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that IPI is not too dependend on debt financing.
IPI's Debt to Equity ratio of 0.00 is amongst the best of the industry. IPI outperforms 96.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.25 | ||
| Altman-Z | 2.74 |
ROIC/WACC0.01
WACC9.24%
2.3 Liquidity
IPI has a Current Ratio of 5.17. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
IPI has a better Current ratio (5.17) than 92.94% of its industry peers.
IPI has a Quick Ratio of 2.62. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
IPI has a Quick ratio of 2.62. This is amongst the best in the industry. IPI outperforms 87.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.17 | ||
| Quick Ratio | 2.62 |
3. Growth
3.1 Past
IPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.67%, which is quite impressive.
IPI shows a small growth in Revenue. In the last year, the Revenue has grown by 0.63%.
Measured over the past years, IPI shows a small growth in Revenue. The Revenue has been growing by 2.96% on average per year.
EPS 1Y (TTM)110.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%378.57%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%23.3%
3.2 Future
The Earnings Per Share is expected to decrease by -4.26% on average over the next years.
The Revenue is expected to decrease by -0.21% on average over the next years.
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue Next Year3.33%
Revenue Next 2Y-0.31%
Revenue Next 3Y-0.21%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IPI is valuated quite expensively with a Price/Earnings ratio of 439.63.
Based on the Price/Earnings ratio, IPI is valued a bit more expensive than the industry average as 68.24% of the companies are valued more cheaply.
IPI is valuated expensively when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
IPI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 439.63 | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as IPI.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPI is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 73.48 | ||
| EV/EBITDA | 10.87 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IPI's earnings are expected to decrease with -4.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)2.22
PEG (5Y)N/A
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
5. Dividend
5.1 Amount
IPI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
35.17
-0.72 (-2.01%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners56.04%
Inst Owner Change-0.78%
Ins Owners1.99%
Ins Owner Change-1.45%
Market Cap468.46M
Analysts42.22
Price Target21.42 (-39.1%)
Short Float %2.64%
Short Ratio1.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)365.13%
Min EPS beat(2)-142.02%
Max EPS beat(2)872.28%
EPS beat(4)1
Avg EPS beat(4)-141.12%
Min EPS beat(4)-1288.12%
Max EPS beat(4)872.28%
EPS beat(8)1
Avg EPS beat(8)-133.02%
EPS beat(12)1
Avg EPS beat(12)-97.98%
EPS beat(16)3
Avg EPS beat(16)-73.69%
Revenue beat(2)2
Avg Revenue beat(2)13.58%
Min Revenue beat(2)9.74%
Max Revenue beat(2)17.42%
Revenue beat(4)4
Avg Revenue beat(4)19.17%
Min Revenue beat(4)9.74%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)23.01%
Revenue beat(12)11
Avg Revenue beat(12)19.62%
Revenue beat(16)15
Avg Revenue beat(16)18.77%
PT rev (1m)0%
PT rev (3m)10.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)625%
EPS NY rev (1m)0%
EPS NY rev (3m)434.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 439.63 | ||
| Fwd PE | N/A | ||
| P/S | 1.71 | ||
| P/FCF | 73.48 | ||
| P/OCF | 11.19 | ||
| P/B | 0.98 | ||
| P/tB | 1.03 | ||
| EV/EBITDA | 10.87 |
EPS(TTM)0.08
EY0.23%
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)0.48
FCFY1.36%
OCF(TTM)3.14
OCFY8.94%
SpS20.51
BVpS35.99
TBVpS34.2
PEG (NY)2.22
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.11% | ||
| ROE | -42.78% | ||
| ROCE | 0.17% | ||
| ROIC | 0.13% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.15% | ||
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 13.64% | ||
| FCFM | 2.33% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score5
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.25 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 91.35% | ||
| Cap/Sales | 13% | ||
| Interest Coverage | 2.22 | ||
| Cash Conversion | 105.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.17 | ||
| Quick Ratio | 2.62 | ||
| Altman-Z | 2.74 |
F-Score5
WACC9.24%
ROIC/WACC0.01
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%378.57%
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue 1Y (TTM)0.63%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%23.3%
Revenue Next Year3.33%
Revenue Next 2Y-0.31%
Revenue Next 3Y-0.21%
Revenue Next 5YN/A
EBIT growth 1Y111.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1489.26%
EBIT Next 3Y128.42%
EBIT Next 5YN/A
FCF growth 1Y132.2%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y-33.63%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%